Human leukemia |
OCI-AML2 |
5, |
Induces cell death through upregulation of ROS. |
[44] |
HL60 |
10, |
U937 |
15, |
K61a |
20 |
Prostate cancer |
DU145 |
|
|
|
PPC-1 |
|
|
|
Human glioblastoma |
U87 |
1, |
Induces growth inhibition, apoptosis and anti-angiogenesis. |
[47] |
|
T98G |
5, |
|
|
10 |
Ovarian cancer |
TYK-nu |
0.1, |
Inhibition of cell proliferation. |
[9] |
KOC7C |
1, |
SKOV3 |
10, |
RMUG-S |
100 |
HEI-193 |
|
Breast cancer |
MDA-MB-435, |
5, |
Stimulates autophagy and inhibition of cell proliferation. |
[54] |
MDA-MB-231 |
10, |
MDA-MB-468 |
15, |
MDA-MB-361 |
20 |
MCF-7 |
|
HS578T |
|
Murine breast cancer |
4T1.2 |
1, |
Induces apoptosis and necrosis. Induces autophagy. |
[50] |
DDHer2 |
4, |
|
8, |
Murine melanoma |
C57BL/6 |
16 |
Inhibition of cell proliferation and clonogenic capacity. |
|
Murine colon adenocarcinoma |
CT.26 |
|
Increases the amount of ROS. |
|
Human breast cancer |
MDA-MB-231 |
|
|
|
MCF7 |
|
|
|
SKBR3 |
|
|
|
Human melanoma |
A2058 |
|
|
|
A375 |
|
|
|
Human pancreatic cancer |
PANC1 |
|
|
|
|
MiaPaca2 |
|
|
|
Human prostate cancer |
DU145 |
|
|
|
Human head and neck cancer |
A253 |
|
|
|
Human leukemia |
MV411 |
|
|
|
Human colon cancer |
CC14 |
0.1, |
Inhibits cell proliferation and induces apoptosis. |
[57] |
CC36 |
1, |
|
|
Ls174T |
5, |
|
|
HT29 |
10 |
|
|
Human glioblastoma |
DLD1 |
|
|
|
U251 |
|
|
|
Human melanoma |
SKMe12 |
|
|
|
Murine breast cancer |
4T1 |
0.01, |
Inhibition of invasiveness and restoration of tamoxifen sensitivity. |
[59] |
|
MMTV-Myc |
0.1, |
|
|
Human breast cancer |
MDA-MB-231 |
1 |
Inhibition of cell growth and metastases. |
|
D3H2LN |
Human breast cancer |
MDA-MB-231 |
0.2, |
Preferentially inhibits cell viability and clonogenicity of the stem cell population. |
[67] |
0.4, |
0.8, |
1, |
5, |
8 |